Literature DB >> 2860350

Low immune responses to hepatitis B vaccination among healthy subjects.

P J Pead, A A Saeed, W G Hewitt, R N Brownfield.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860350     DOI: 10.1016/s0140-6736(85)92449-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Immunogenicity of hepatitis B vaccine (HEVAC B) in children with advanced renal failure.

Authors:  G Pillion; M Chiesa; A Maisin; N Schlegel; C Loirat
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

2.  Immune response to hepatitis B vaccine given at different injection sites and by different routes: a controlled randomized study.

Authors:  F de Lalla; E Rinaldi; D Santoro; G Pravettoni
Journal:  Eur J Epidemiol       Date:  1988-06       Impact factor: 8.082

3.  Immunogenicity of plasma-derived hepatitis B vaccine: relationship to site of injection and obesity.

Authors:  S M Lemon; D J Weber
Journal:  J Gen Intern Med       Date:  1986 May-Jun       Impact factor: 5.128

4.  Hepatitis B vaccination: effect of re-vaccination and injection site in suboptimal responders.

Authors:  P J Pead; A A Saeed
Journal:  Eur J Epidemiol       Date:  1986-09       Impact factor: 8.082

5.  Influence of skin-to-muscle and muscle-to-bone thickness on depth of needle penetration in adults at the deltoid intramuscular injection site.

Authors:  Nachiket Shankar; Deepali Saxena; Pooja P Lokkur; Nikhil M Kumar; Neena Chris William; Nirupama Vijaykumar
Journal:  Med J Armed Forces India       Date:  2014-10-16

6.  A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.

Authors:  Y Itoh; E Takai; H Ohnuma; K Kitajima; F Tsuda; A Machida; S Mishiro; T Nakamura; Y Miyakawa; M Mayumi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.